Primary tumours are curable but secondary tumours are not. Biomedcore develops proprietary zebrafish models that enables to create patient specific cancer models using few cells from blood of a patient. So a Zgraft is a particular patient’s cancer avatar. Now these avatars can then be monitored for the cancer’s ability to progress, and cancer's drug sensitivity, all with no discomfort to the patient.